U.S. Wound Gel Market Size, Share & Trends Analysis Report By Product (Dressings, Gels), By Antimicrobial Properties (Silver (Ag+), Non-Silver), By Application, By End-use, By Mode Of Purchase, By Distribution Channel, And Segment Forecasts, 2025

The U.S. wound gel market size was estimated at USD 2.11 billion in 2024 and is expected to grow at a CAGR of 5.71% from 2025 to 2033 to reach USD 3.47 billion by 2033. This growth is attributed to the rising prevalence of chronic wounds, increasing demand for advanced wound care solutions, a growing elderly population, and continuous innovations in hydrogel formulations that enhance healing outcomes. In addition, the shift toward outpatient and home-based care and supportive reimbursement policies is further accelerating market expansion.

According to data from the U.S. Census Bureau, by 2025, the population's average age is expected to reach 40 years, with approximately 60 million individuals aged 65 years or older accounting for 18% of the total population. Among them, 4% will be 80 years or older. By 2050, the number of elderly individuals is projected to rise to 80 million, representing 25% of the population aged 65 and above, while those aged 80 and over will comprise 8%.

The increasing demand for wound gel products from the U.S. military and defense sector is emerging as a significant market driver, primarily due to combat and field operations' unique and high-risk nature. Military personnel are frequently exposed to traumatic injuries, including lacerations, burns, and deep wounds, which require immediate, efficient, and infection-resistant treatment in austere environments where traditional surgical care is not readily available. In such scenarios, wound gels offer a practical solution-they are portable, easy to apply, and provide moisture-retentive healing environments that promote faster tissue regeneration while minimizing infection risks.

Furthermore, the U.S. Department of Defense has collaborated with biotechnology firms to develop advanced hydrogel formulations, including enzyme-based or antimicrobial wound gels designed specifically for battlefield use. For instance, in November 2024, the U.S. Army partnered with SolasCure, a Cambridge-based biotechnology company, to evaluate the company's investigational wound care hydrogel, Aurase Wound Gel, in military settings. Aurase wound gel features a recombinant enzyme, tarumase, derived initially from maggots. This enzyme is highly effective in enzymatic debridement, removing dead tissue and preparing the wound bed, offering a biologically inspired solution for wound management that supports natural and alternative healing approaches.

U.S. Wound Gel Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. wound gel market report based on product, antimicrobial properties, application, distribution channel, mode of purchase, and end-use:

Product Outlook (Revenue, USD Million, 2021 - 2033)
Dressings
- Hydrogel dressing
- Gelling fiber dressings
- Others
Gels
Antimicrobial Properties Outlook (Revenue, USD Million, 2021 - 2033)
Silver (Ag+)
Non-Silver
Application Outlook (Revenue, USD Million, 2021 - 2033)
Chronic Wounds
- Diabetic Foot Ulcers (DFUs)
- Pressure Ulcers
- Stage 1
- Stage 2
- Stage 3
- Stage 4
- Leg Ulcers
Acute Wounds
- Surgical Incisions
- Burns
- 1st Degree
- 2nd Degree
- 3rd Degree
- Lacerations, Abrasions
Mode of Purchase Outlook (Revenue, USD Million, 2021 - 2033)
Prescription
Non-prescription
Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
Offline
Online
End-use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals
Specialty Clinics
Ambulatory Surgery Centers
Homecare Settings
Long-Term Care Facilities
Others

Product Code: GVR-4-68040-621-3

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Antimicrobial Properties
- 1.2.3. Application
- 1.2.4. Distribution Channel
- 1.2.5. Mode of Purchase
- 1.2.6. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. U.S. Wound Gel Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Shift towards home healthcare
  - 3.2.1.2. Technological advancements
  - 3.2.1.3. Rising Prevalence of Chronic Diseases
  - 3.2.1.4. Rising aging population in the U.S.
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Stringent regulatory environment
  - 3.2.2.2. Limited reimbursement policies
- 3.2.3. Market Opportunities Analysis
  - 3.2.3.1. Increasing demand for wound gel products from the military and defense sector
- 3.2.4. Market Challenge Analysis
  - 3.2.4.1. Rising competition among industry participants
3.3. U.S. Wound Gel Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Bargaining power of suppliers
  - 3.3.1.2. Bargaining power of buyers
  - 3.3.1.3. Threat of substitutes
  - 3.3.1.4. Threat of new entrants
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political & Legal Landscape
  - 3.3.2.2. Economic and Social Landscape
  - 3.3.2.3. Technological landscape

Chapter 4. U.S. Wound Gel Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. U.S. Wound Gel Market Movement Analysis
4.3. U.S. Wound Gel Market Size & Trend Analysis, by Product, 2021 - 2033 (USD Million)
4.4. Dressings
- 4.4.1. Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.2. Hydrogel Dressing
  - 4.4.2.1. Hydrogel Dressing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.3. Gelling Fiber Dressings
  - 4.4.3.1. Gelling Fiber Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.4. Others
  - 4.4.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Gels
- 4.5.1. Gels Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Wound Gel Market: Antimicrobial Properties Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. U.S. Wound Gel Market Movement Analysis
5.3. U.S. Wound Gel Market Size & Trend Analysis, by Antimicrobial Properties, 2021 to 2033 (USD Million)
5.4. Silver (Ag+)
- 5.4.1. Silver (Ag+) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Non-Silver
- 5.5.1. Non-Silver Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Wound Gel Market: Application Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. U.S. Wound Gel Market Movement Analysis
6.3. U.S. Wound Gel Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Chronic Wounds
- 6.4.1. Chronic Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.2. Diabetic Foot Ulcers (DFUs)
  - 6.4.2.1. Diabetic Foot Ulcers (DFUs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.3. Pressure Ulcers
  - 6.4.3.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 6.4.3.2. Stage 1
    - 6.4.3.2.1. Stage 1 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 6.4.3.3. Stage 2
    - 6.4.3.3.1. Stage 2 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 6.4.3.4. Stage 3
    - 6.4.3.4.1. Stage 3 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 6.4.3.5. Stage 4
    - 6.4.3.5.1. Stage 4 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.4. Leg Ulcers
  - 6.4.4.1. Leg Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Acute Wounds
- 6.5.1. Acute Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.2. Surgical Incisions
  - 6.5.2.1. Surgical Incisions Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.3. Burns
  - 6.5.3.1. Burns Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 6.5.3.2. 1st Degree
    - 6.5.3.2.1. 1st Degree Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 6.5.3.3. 2nd Degree
    - 6.5.3.3.1. 2nd Degree Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 6.5.3.4. 3rd Degree
    - 6.5.3.4.1. 3rd Degree Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.4. Lacerations, Abrasions
  - 6.5.4.1. Lacerations, Abrasions Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Wound Gel Market: Distribution Channel Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. U.S. Wound Gel Market Movement Analysis
7.3. U.S. Wound Gel Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
7.4. Online
- 7.4.1. Online Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Offline
- 7.5.1. Offline Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. U.S. Wound Gel Market: Mode of Purchase Estimates & Trend Analysis

8.1. Segment Dashboard
8.2. U.S. Wound Gel Market Movement Analysis
8.3. U.S. Wound Gel Market Size & Trend Analysis, by Mode of Purchase, 2021 to 2033 (USD Million)
8.4. Prescription
- 8.4.1. Prescription Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Non-prescription
- 8.5.1. Non-prescription Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. U.S. Wound Gel Market: End Use Estimates & Trend Analysis

9.1. Segment Dashboard
9.2. U.S. Wound Gel Market Movement Analysis
9.3. U.S. Wound Gel Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
9.4. Hospitals
- 9.4.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5. Specialty Clinics
- 9.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6. Ambulatory Surgery Center
- 9.6.1. Ambulatory Surgery Center Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.7. Homecare Settings
- 9.7.1. Homecare Settings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.8. Long-Term Care Facilities
- 9.8.1. Long-Term Care Facilities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.9. Others
- 9.9.1. Long-term Care (residential living setting) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

10.1. Market Participant Categorization
10.2. Key Company Profiles
10.3. Company Share Analysis, 2024
- 10.3.1. Medline Industries, LP.
  - 10.3.1.1. Company Overview
  - 10.3.1.2. Financial Performance
  - 10.3.1.3. Product Benchmarking
  - 10.3.1.4. Strategic Initiatives
- 10.3.2. Coloplast Corp
  - 10.3.2.1. Company Overview
  - 10.3.2.2. Financial Performance
  - 10.3.2.3. Product Benchmarking
  - 10.3.2.4. Strategic Initiatives
- 10.3.3. Molnlycke Health Care AB
  - 10.3.3.1. Company Overview
  - 10.3.3.2. Financial Performance
  - 10.3.3.3. Product Benchmarking
  - 10.3.3.4. Strategic Initiatives
- 10.3.4. Solventum
  - 10.3.4.1. Company Overview
  - 10.3.4.2. Financial Performance
  - 10.3.4.3. Product Benchmarking
  - 10.3.4.4. Strategic Initiatives
- 10.3.5. Convatec Inc.
  - 10.3.5.1. Company Overview
  - 10.3.5.2. Financial Performance
  - 10.3.5.3. Product Benchmarking
  - 10.3.5.4. Strategic Initiatives
- 10.3.6. Cresilon
  - 10.3.6.1. Company Overview
  - 10.3.6.2. Financial Performance
  - 10.3.6.3. Product Benchmarking
  - 10.3.6.4. Strategic Initiatives
- 10.3.7. Smith+Nephew
  - 10.3.7.1. Company Overview
  - 10.3.7.2. Financial Performance
  - 10.3.7.3. Product Benchmarking
  - 10.3.7.4. Strategic Initiatives
- 10.3.8. B. Braun SE
  - 10.3.8.1. Company Overview
  - 10.3.8.2. Financial Performance
  - 10.3.8.3. Product Benchmarking
  - 10.3.8.4. Strategic Initiatives
- 10.3.9. DermaRite Industries, LLC.
  - 10.3.9.1. Company Overview
  - 10.3.9.2. Financial Performance
  - 10.3.9.3. Product Benchmarking
  - 10.3.9.4. Strategic Initiatives
- 10.3.10. Integra LifeSciences Corporation
  - 10.3.10.1. Company Overview
  - 10.3.10.2. Financial Performance
  - 10.3.10.3. Product Benchmarking
  - 10.3.10.4. Strategic Initiatives
- 10.3.11. Sanara MedTech Inc.
  - 10.3.11.1. Company Overview
  - 10.3.11.2. Financial Performance
  - 10.3.11.3. Product Benchmarking
  - 10.3.11.4. Strategic Initiatives

Product Code: GVR-4-68040-621-3

List of Tables

Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. U.S. Wound Gel Market, by Product, 2021 - 2033 (USD Million)
Table 4. U.S. Wound Gel Market, by Antimicrobial Properties, 2021 - 2033 (USD Million)
Table 5. U.S. Wound Gel Market, by Application, 2021 - 2033 (USD Million)
Table 6. U.S. Wound Gel Market, by Distribution Channel, 2021 - 2033 (USD Million)
Table 7. U.S. Wound Gel Market, by Mode of Purchase, 2021 - 2033 (USD Million)
Table 8. U.S. Wound Gel Market, by End Use, 2021 - 2033 (USD Million)
Table 9. Participant's Overview
Table 10. Financial Performance
Table 11. Product Benchmarking
Table 12. Strategic Initiatives

List of Figures

Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 U.S. Wound Gel Market, Market Segmentation
Fig. 7 Market Driver Analysis (Current & Future Impact)
Fig. 8 Market Restraint Analysis (Current & Future Impact)
Fig. 9 Market Opportunity Analysis (Current & Future Impact)
Fig. 10 Market Challenge Analysis (Current & Future Impact)
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
Fig. 12 Porter's Five Forces Analysis
Fig. 13 Regional Marketplace: Key Takeaways
Fig. 14 U.S. Wound Gel Market, for Product, 2021 - 2033 (USD Million)
Fig. 15 U.S. Wound Gel Market, for Dressings, 2021 - 2033 (USD Million)
Fig. 16 U.S. Wound Gel Market, for Hydrogel Dressing, 2021 - 2033 (USD Million)
Fig. 17 U.S. Wound Gel Market, for Gelling Fiber Dressings, 2021 - 2033 (USD Million)
Fig. 18 U.S. Wound Gel Market, for Others, 2021 - 2033 (USD Million)
Fig. 19 U.S. Wound Gel Market, for Gels, 2021 - 2033 (USD Million)
Fig. 20 U.S. Wound Gel Market, for Antimicrobial Properties, 2021 - 2033 (USD Million)
Fig. 21 U.S. Wound Gel Market, for Silver (Ag+), 2021 - 2033 (USD Million)
Fig. 22 U.S. Wound Gel Market, for Non-Silver, 2021 - 2033 (USD Million)
Fig. 23 U.S. Wound Gel Market, for Application, 2021 - 2033 (USD Million)
Fig. 24 U.S. Wound Gel Market, for Chronic Wounds, 2021 - 2033 (USD Million)
Fig. 25 U.S. Wound Gel Market, for Diabetic Foot Ulcers (DFUs), 2021 - 2033 (USD Million)
Fig. 26 U.S. Wound Gel Market, for Pressure Ulcers, 2021 - 2033 (USD Million)
Fig. 27 U.S. Wound Gel Market, for Stage 1, 2021 - 2033 (USD Million)
Fig. 28 U.S. Wound Gel Market, for Stage 2, 2021 - 2033 (USD Million)
Fig. 29 U.S. Wound Gel Market, for Stage 3, 2021 - 2033 (USD Million)
Fig. 30 U.S. Wound Gel Market, for Stage 4, 2021 - 2033 (USD Million)
Fig. 31 U.S. Wound Gel Market, for Leg Ulcers, 2021 - 2033 (USD Million)
Fig. 32 U.S. Wound Gel Market, for Acute Wound, 2021 - 2033 (USD Million)
Fig. 33 U.S. Wound Gel Market, for Surgical Incisions, 2021 - 2033 (USD Million)
Fig. 34 U.S. Wound Gel Market, for Burns, 2021 - 2033 (USD Million)
Fig. 35 U.S. Wound Gel Market, for 1st Degree, 2021 - 2033 (USD Million)
Fig. 36 U.S. Wound Gel Market, for 2nd Degree, 2021 - 2033 (USD Million)
Fig. 37 U.S. Wound Gel Market, for 3rd Degree, 2021 - 2033 (USD Million)
Fig. 38 U.S. Wound Gel Market, for Lacerations, Abrasions, 2021 - 2033 (USD Million)
Fig. 39 U.S. Wound Gel Market, for End Use, 2021 - 2033 (USD Million)
Fig. 40 U.S. Wound Gel Market, for Hospitals, 2021 - 2033 (USD Million)
Fig. 41 U.S. Wound Gel Market, for Specialty Clinics, 2021 - 2033 (USD Million)
Fig. 42 U.S. Wound Gel Market, for Ambulatory Surgery Centers, 2021 - 2033 (USD Million)
Fig. 43 U.S. Wound Gel Market, for Homecare Settings, 2021 - 2033 (USD Million)
Fig. 44 U.S. Wound Gel Market, for Long-Term Care Facilities, 2021 - 2033 (USD Million)
Fig. 45 U.S. Wound Gel Market, for Others, 2021 - 2033 (USD Million)
Fig. 46 U.S. Wound Gel Market, for Distribution Channel, 2021 - 2033 (USD Million)
Fig. 47 U.S. Wound Gel Market, for Offline, 2021 - 2033 (USD Million)
Fig. 48 U.S. Wound Gel Market, for Online, 2021 - 2033 (USD Million)
Fig. 49 U.S. Wound Gel Market, for Mode of Purchase, 2021 - 2033 (USD Million)
Fig. 50 U.S. Wound Gel Market, for Prescription, 2021 - 2033 (USD Million)
Fig. 51 U.S. Wound Gel Market, for Non-prescription, 2021

U.S. Wound Gel Market Size, Share & Trends Analysis Report By Product (Dressings, Gels), By Antimicrobial Properties (Silver (Ag+), Non-Silver), By Application, By End-use, By Mode Of Purchase, By Distribution Channel, And Segment Forecasts, 2025 - 2033

Description

Table of Contents

List of Tables

U.S Wound Gel Market Size & Trends:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. U.S. Wound Gel Market Variables, Trends, & Scope

Chapter 4. U.S. Wound Gel Market: Product Estimates & Trend Analysis

Chapter 5. U.S. Wound Gel Market: Antimicrobial Properties Estimates & Trend Analysis

Chapter 6. U.S. Wound Gel Market: Application Estimates & Trend Analysis

Chapter 7. U.S. Wound Gel Market: Distribution Channel Estimates & Trend Analysis

Chapter 8. U.S. Wound Gel Market: Mode of Purchase Estimates & Trend Analysis

Chapter 9. U.S. Wound Gel Market: End Use Estimates & Trend Analysis

Chapter 10. Competitive Landscape

List of Tables

List of Figures